Welcome to LookChem.com Sign In|Join Free

CAS

  • or

850074-44-1

ethyl 6-formylbenzothiophene-2-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

850074-44-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 850074-44-1 Structure

  • Basic information

    1. Product Name: ethyl 6-formylbenzothiophene-2-carboxylate
    2. Synonyms: ethyl 6-formyl-1-benzothiophene-2-carboxylate; Ethyl-6-formyl-1-benzothiophen-2-carboxylat
    3. CAS NO:850074-44-1
    4. Molecular Formula: C12H10O3S
    5. Molecular Weight: 234.27
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 850074-44-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 384.8°C at 760 mmHg
    3. Flash Point: 186.5°C
    4. Appearance: N/A
    5. Density: 1.308g/cm3
    6. Vapor Pressure: 3.97E-06mmHg at 25°C
    7. Refractive Index: 1.653
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: ethyl 6-formylbenzothiophene-2-carboxylate(CAS DataBase Reference)
    11. NIST Chemistry Reference: ethyl 6-formylbenzothiophene-2-carboxylate(850074-44-1)
    12. EPA Substance Registry System: ethyl 6-formylbenzothiophene-2-carboxylate(850074-44-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 850074-44-1(Hazardous Substances Data)

850074-44-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 850074-44-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,0,7 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 850074-44:
(8*8)+(7*5)+(6*0)+(5*0)+(4*7)+(3*4)+(2*4)+(1*4)=151
151 % 10 = 1
So 850074-44-1 is a valid CAS Registry Number.

850074-44-1Relevant articles and documents

ORTHO AMINOAMIDES FOR THE TREATMENT OF CANCER

-

Page/Page column 88, (2010/09/05)

Compounds of formula are HDAC inhibitors. These compounds are useful for the treatment of diseases such as cancer in humans or animals.

Benzo[b]thiophene-based histone deacetylase inhibitors

Witter, David J.,Belvedere, Sandro,Chen, Liqiang,Secrist, J. Paul,Mosley, Ralph T.,Miller, Thomas A.

, p. 4562 - 4567 (2008/02/11)

Benzo[b]thienyl hydroxamic acids, a novel class of histone deacetylase (HDAC) inhibitors, were identified via a targeted screen of small molecule hydroxamic acids. Various substitutions were explored in the C5- and C6-positions of the benzo[b]thiophene co

BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES

-

, (2008/06/13)

The present invention relates to a novel class of hydroxamic acid derivatives. The hydroxamic acid compounds can be used to treat cancer. The hydroxamic acid compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing t

BENZOTHIOPHENE DERIVATIVES

-

, (2008/06/13)

The present invention relates to a novel class of benzothiophene amide derivatives. The hydroxamic acid compounds can be used to treat cancer. The benzothiophene amide compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the hydroxamic acid derivatives and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of the hydroxamic acid derivatives in vivo.

THIOPHENE AND BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES

-

, (2008/06/13)

The present invention relates to a novel class of hydroxamic acid derivatives having a benzothiophene or thiophene backbone. The hydroxamic acid compounds can be used to treat cancer. The hydroxamic acid compounds can also inhibit historic deacetylase and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 850074-44-1